Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. The company is headquartered in Commack, New York and currently employs 14 full-time employees. The company went IPO on 2020-02-18. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The firm's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
Basado en 7 analistas que dan calificaciones de acciones a SCNX, actualizado el Mar 01, 2024
Buy
Strong buy
2
Buy
4
Hold
1
Sell
0
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for SCNX. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: SCNX is a Buy candidate.
SCNX stock price ended at $0.53 on viernes, after rising 1.92%
On the latest trading day Jan 16, 2026, the stock price of SCNX rose by 1.92%, climbing from $0.51 to $0.53. Throughout the session, the stock experienced a volatility of 3.92%, with prices fluctuating between a daily low of $0.51 and a high of $0.53. Alongside this price increase, trading volume also rose by 877.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 121.7K shares were traded, amounting to a market value of approximately $21.5M.
Señales Técnicas de SCNX
Resumen de Señales Técnicas
Señales de compra 2
Señales Neutras 2
Señales de venta 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
SCNX actualmente presenta 2 señales de compra y 3 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de 1.92% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Sell para el mediano plazo.
Señales alcistas/bajistas para SCNX
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para SCNX. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.
Preguntas de seguimiento
¿Cómo se aplican los indicadores de análisis técnico a SCNX?
¿Cuáles son los niveles de retroceso de Fibonacci para SCNX?
¿Cuál es el RSI de Scienture Holdings Inc?
¿Cuál es el precio de Scienture Holdings Inc para los próximos 12 meses?
¿Hasta dónde se espera que suba Scienture Holdings Inc?